Peer Review History

Original SubmissionOctober 23, 2023
Decision Letter - Keumseok Peter Koh, Editor

PONE-D-23-34732An Agent-Based Model of the Spread of Behavioural Risk-Factors for Cardiovascular Disease in City-Scale PopulationsPLOS ONE

Dear Dr. Griffiths,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Keumseok Peter Koh

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review the article “An Agent-Based Model of the Spread of Behavioural Risk-Factors for Cardiovascular Disease in City-Scale Populations. It is a well-written paper strongly founded on robust predictive modelling. I greatly appreciate the efforts of the authors. However, I have a few suggestions to strengthen the article further.

I have a few suggestions and observations related to the model

1. I see a possibility of extending the simulation with more factors, like

a. Common mental disorders like stress, anxiety, and depression have shown a significant association with behavioural risk factors. Therefore, how does the model address these intervening factors? It is not clear from the manuscript.

b. The genetic loading of CVD is not included in the model, as it could be a confounder. To my knowledge, behavioral aspects are only one of the various genetic, cognitive and social risk factors of CVD

2. Comparing with a network model like the Stochastic Block Model (SBM)/ or a centrality measure that considers influence strength would enhance the model's robustness by capturing the higher likelihood of interactions within the same neighbourhood.

3. The manuscript does not account for temporal dynamics, such as the short-term and long-term effects of behaviours on cardiovascular health.

4. Conduct sensitivity analyses to assess the impact of varying parameters on model outcomes

Reviewer #2: This is a clear and well written text that describes an agent based model of the reinforcement or mitigation of CVD behavioral risk factors by spousal, household, friendship and workplace networks. The model is well described and compelling with one drawback that is leading me to recommend major revision. The various networks are created during initialization and then remain static over the course of the simulated 10 year run. The static nature of the networks seems perhaps reasonable for spouse and household, but less so for friendship and workplace networks. The authors address this shortcoming in the "Limitations of the ABM Model" section, but not satisfactorily. The strength and central focus of the paper is the network mediated influence and stating that "the population in the ABM can be considered as a cohort that persists throughout the simulation process" undermines that focus. If the CVD behavioral risk factors are network mediated then the static nature cannot be dismissed so easliy. More needs to be said about why the static nature of the networks doesn't break the model, perhaps with additional experiments that do change the networks to illustrate what sort of effect, in the abstract, this might have. In addition, workplace assignment as described in the synthetic population literature may also offer some insight into workplace turnover. With respect to dynamic networks, the authors may also want to look at "ERGMs" (https://eehh-stanford.github.io/SNA-workshop/ergm-intro.html). More specific comments follow.

In the Related Work section, some brief discussion of synthetic population construction would be useful.

line 38. "the evolution", maybe better as "their evolution" or "the evoluion of ...".

l. 65 The two influence models need citations. They are cited later, but this is their first mention, I think.

In the "Basic Agent Attributes" section, it would be useful to explicitly mention that the agent's have the risk factor attributes as well as age, sex, and socio-economic status. This is obvious once the model is further described, but would be good here as well to avoid any confusion. With respect to the attributes, the authors state "these attributes have a significant effect on an agent’s likelihood of developing CVD, and are considered in combination with the impact of the behavioural risk factors described below". Further in the text, when creating the population and assigning CVD risk factors, age and sex are used, but it's unclear how socio-economic status (IMD) effects CVD in the model.

With respect to behavior spread, why 1 year time steps?

l. 371 - no need to unpack CSV, already seen on page 12.

l. 408 - Missing dash in Hippisley Cox. This occurs in other places as well.

Calibration Section - some text about the stochastic nature of the model, and the range of variation between runs with different seeds, and how many runs are necessary to characterize the model's output would be useful, assuming this applies.

Results - some text about why some age ranges do better / worse that others would help to explain the results.

Intervention - why does the baseline model against which intervention is applied have no workplace influence. More accurate / realistic would be a calibrated real-world reasonable level of workplace influence that is then modified by the intervention, unless the experiment is only to show that an intervention can have an effect in the abstract. If it's the latter, then that should be made more explicit.

l. 507 -- isn't the maximum absolute difference 7.86?

Is citation 39, the same as 3?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see the "Response to reviewers" file for a detailed response. We believe that we have addressed the Reviewers' concerns.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Keumseok Peter Koh, Editor

An Agent-Based Model of the Spread of Behavioural Risk-Factors for Cardiovascular Disease in City-Scale Populations

PONE-D-23-34732R1

Dear Dr. Griffiths,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Keumseok Peter Koh

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for your submission and the long waiting for the final decision. It was very challenging to have enough reviewers on the right time since your ABM of CVDs are novel and pioneering. I believe your approach can inspire other ABM modellers for further studies in chronic diseases.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review the

article “An Agent-Based Model of the Spread of

Behavioural risk factors for Cardiovascular

Disease in City-Scale Populations. I greatly appreciate the

efforts of the authors to address all my questions and suggestions.

Regarding the first suggestion, the authors expressed their inability to find the relevant data and discussed it in a discussion section, which gives the readers better clarity.

The second observation was also clarified in the discussion section satisfactorily

The third and fourth observations were also well-addressed.

I appreciate the efforts taken by the authors to thoroughly revise the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Saju Madavanakadu Devassy

**********

Formally Accepted
Acceptance Letter - Keumseok Peter Koh, Editor

PONE-D-23-34732R1

PLOS ONE

Dear Dr. Griffiths,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Keumseok Peter Koh

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .